Department of Radiotherapy Oncology, First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an, People's Republic of China.
Onco Targets Ther. 2013 Apr 2;6:297-302. doi: 10.2147/OTT.S41538. Print 2013.
Regimens that combine chemotherapy and radiotherapy increase toxicity and compromise a patient's ability to adhere to the treatment plan. We evaluated the efficacy and safety of a partially completed chemoradiation regimen prescribed for locally advanced carcinoma of the cervix.
Medical records of 156 patients with locally advanced cervical cancer stage IIB-IVA who received chemoradiation with cisplatin (40 mg/m(2)) and 5-fluorouracil (500 mg/ m(2)) from October 2006 to October 2008 were collected. The treatment protocol called for two cycles of chemotherapy. External beam radiation therapy was administered using a 10-MeV electron beam. Local control, disease free survival, overall survival, and toxicities were evaluated.
With a median follow-up of 37.5 months, 89 patients (57%) completed the planned protocol. Sixty seven patients (43%) completed fewer than two cycles. The 3-year local control rate was significantly better in the patient group that completed the prescribed plan (92.1% compared to 80.6%; P = 0.033). No statistical significance was observed between the groups that completed or did not complete the two cycle protocol with regard to disease free survival (80.9% and 73.2%, respectively; P = 0.250), overall survival (84.3% and 79.1%; P = 0.405), and progression survival (3.4% and 3.0%; P = 0.892). Differences in acute hematologic toxicity and subcutaneous toxicity were observed between the two groups.
Completion of two cycles of 5-fluorouracil and cisplatin with radiotherapy was effective, safe, and responsible for better local control; toxicity was acceptable. Disease free survival and overall survival were similar between the treatment groups.
联合化疗和放疗的方案会增加毒性,使患者难以坚持治疗计划。我们评估了局部晚期宫颈癌部分完成的放化疗方案的疗效和安全性。
收集了 2006 年 10 月至 2008 年 10 月接受顺铂(40mg/m²)和 5-氟尿嘧啶(500mg/m²)联合放化疗的 156 例局部晚期宫颈癌 IIB-IVA 患者的病历。该治疗方案包括两个周期的化疗。采用 10-MeV 电子束进行外照射放疗。评估局部控制、无病生存率、总生存率和毒性。
中位随访 37.5 个月,89 例患者(57%)完成了计划方案。67 例患者(43%)完成少于两个周期。完成规定方案的患者组 3 年局部控制率明显更好(92.1%比 80.6%;P=0.033)。完成或未完成两个周期方案的两组之间,无病生存率(分别为 80.9%和 73.2%;P=0.250)、总生存率(分别为 84.3%和 79.1%;P=0.405)和进展生存率(分别为 3.4%和 3.0%;P=0.892)均无统计学差异。两组之间观察到急性血液学毒性和皮下毒性存在差异。
完成两个周期的氟尿嘧啶和顺铂联合放疗是有效、安全的,并且可以更好地控制局部病情;毒性可接受。两组之间无病生存率和总生存率相似。